Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Al Ozonoff

Showing results (231-240 of 259) with videos related to

Pageof 26
Sort By:
Science Translational Medicine|April 17, 2024
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathologyHoang Van Phan, Alexandra Tsitsiklis, Cole P Maguire, et al.
Vaccine|July 27, 2025
Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkersJoann Diray-Arce, Ana C Chang, Sara Moradipoor, et al.
The Journal of Allergy and Clinical Immunology. Global|March 11, 2026
A randomized prospective study of neonatal hepatitis B vaccine immunogenicity in The Gambia and Papua New GuineaJoann Diray-Arce, Caitlin Syphurs, Annmarie Hoch, et al.
JCI Insight|November 10, 2025
Minimalistic transcriptomic signatures permit accurate early prediction of COVID-19 mortalityRithwik Narendra, Emily C Lydon, Hoang Van Phan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
Minimalistic Transcriptomic Signatures Permit Accurate Early Prediction of COVID-19 MortalityRithwik Narendra, Emily C Lydon, Hoang Van Phan, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2021
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunityEtsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
The Journal of Clinical Investigation|May 1, 2024
Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortalityJeremy P Gygi, Cole Maguire, Ravi K Patel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2025
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC studyKoji Abe, Tyson H Holmes, Tran T Nguyen, et al.
Nature Communications|March 14, 2019
Dynamic molecular changes during the first week of human life follow a robust developmental trajectoryAmy H Lee, Casey P Shannon, Nelly Amenyogbe, et al.
Ebiomedicine|August 11, 2022
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC studyAl Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Pageof 26

Showing results (231-240 of 259) with videos related to

Sort By:
Pageof 26
Science Translational Medicine|April 17, 2024
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathologyHoang Van Phan, Alexandra Tsitsiklis, Cole P Maguire, et al.
Vaccine|July 27, 2025
Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkersJoann Diray-Arce, Ana C Chang, Sara Moradipoor, et al.
The Journal of Allergy and Clinical Immunology. Global|March 11, 2026
A randomized prospective study of neonatal hepatitis B vaccine immunogenicity in The Gambia and Papua New GuineaJoann Diray-Arce, Caitlin Syphurs, Annmarie Hoch, et al.
JCI Insight|November 10, 2025
Minimalistic transcriptomic signatures permit accurate early prediction of COVID-19 mortalityRithwik Narendra, Emily C Lydon, Hoang Van Phan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
Minimalistic Transcriptomic Signatures Permit Accurate Early Prediction of COVID-19 MortalityRithwik Narendra, Emily C Lydon, Hoang Van Phan, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2021
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunityEtsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
The Journal of Clinical Investigation|May 1, 2024
Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortalityJeremy P Gygi, Cole Maguire, Ravi K Patel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2025
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC studyKoji Abe, Tyson H Holmes, Tran T Nguyen, et al.
Nature Communications|March 14, 2019
Dynamic molecular changes during the first week of human life follow a robust developmental trajectoryAmy H Lee, Casey P Shannon, Nelly Amenyogbe, et al.
Ebiomedicine|August 11, 2022
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC studyAl Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Pageof 26